Ahmet H Elmaagacli
Overview
Explore the profile of Ahmet H Elmaagacli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
611
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elmaagacli A, Jehn C, Shikova Y, Huber M, Salwender H, Dahmash F, et al.
Leuk Lymphoma
. 2019 Oct;
61(2):485-487.
PMID: 31566043
No abstract available.
2.
Elmaagacli A, Salwender H, Jehn C, Dahmash F, Singh A, Wilson O, et al.
Leuk Lymphoma
. 2019 Jun;
60(13):3335-3338.
PMID: 31164030
No abstract available.
3.
Koldehoff M, Lindemann M, Ross S, Elmaagacli A
PLoS One
. 2018 Jan;
13(1):e0191482.
PMID: 29377903
Cytomegalovirus (HCMV) reactivation is found frequently after allogeneic hematopoietic stem cell transplantation (alloSCT) and is associated with an increased treatment-related mortality. Recent reports suggest a link between HCMV and a...
4.
Koldehoff M, Ross S, Duhrsen U, Beelen D, Elmaagacli A
Leuk Lymphoma
. 2016 Oct;
58(4):822-833.
PMID: 27687578
A preventive effect of early human cytomegalovirus (HCMV) replication was evaluated in 136 non-Hodgkin lymphoma (NHL) patients with mature B-cell NHLs (n = 94), and mature T- and NK-cell NHLs...
5.
6.
Koldehoff M, Lindemann M, Opalka B, Bauer S, Ross R, Elmaagacli A
Leuk Lymphoma
. 2015 Mar;
56(11):3189-97.
PMID: 25818505
Cytomegalovirus (HCMV) reactivation occurs frequently after hematopoietic stem cell transplantation and is associated with an increased treatment-related mortality. Induction of apoptosis by HCMV is unusual because HCMV utilizes various strategies...
7.
Elmaagacli A
Methods Mol Biol
. 2014 Jan;
1109:187-207.
PMID: 24473785
The monitoring of minimal residual disease (MRD) in patients with acute or chronic myeloid disorders is performed routinely after allogeneic or autologous transplantation. The detection of MRD helps to identify...
8.
Elmaagacli A
Biol Blood Marrow Transplant
. 2013 Nov;
20(1):1-2.
PMID: 24216183
No abstract available.
9.
Koldehoff M, Cierna B, Steckel N, Beelen D, Elmaagacli A
J Reprod Immunol
. 2013 Aug;
99(1-2):62-8.
PMID: 23958292
We examined the molecular characteristics of monocytes of pregnant and non-pregnant women to investigate the molecular effects that are associated with immunoregulation at the maternal-fetal interface. We analyzed molecular features...
10.
Koldehoff M, Elmaagacli A
Cell Biol Int
. 2013 Apr;
37(8):766-7.
PMID: 23554022
No abstract available.